Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Home›Research›Companies

Companies

Loading

BMI OrganBank

AddedMay 5, 2026

UpdatedMay 30, 2026

BMI OrganBank

Series A

BMI OrganBank develops organ preservation platforms for transplant decisions.

HQ

Winston-Salem, NC, US

Founded

BMI OrganBank develops next-generation organ preservation platforms that use bloodless, room-temperature machine perfusion to maintain donor organs in a physiologically active state. Its OrganBank Kidney platform generates continuous functional data during preservation, enabling real-time assessment and supporting higher-confidence clinical decisions for transplant teams.

The company partners with leading academic institutions including Duke University, Atrium Health, and Wake Forest University School of Medicine. It has secured FDA Breakthrough Device designation for its kidney preservation technology and is preparing for clinical trials in 2026.

BMI OrganBank - Similar Companies

BiomedInnovations

TransMedics

transmedics.com

Miromatrix Medical

miromatrix.com

Paragonix Technologies

Bridge to Life

bridgetolife.com

X-Therma

x-therma.com

Implantable Artificial Kidney

Vascular Perfusion Solutions

eGenesis

egenesisbio.com

Perfusion Medical

Pinnacle Transplant Technologies

Biomimedica

biomimedica.com

Velomedix

Mercury Biomed

Tissue Genesis

tissuegenesis.com

BMI OrganBank - Quick Facts

Who are BMI OrganBank's competitors?

Companies similar to BMI OrganBank include BiomedInnovations, TransMedics, Miromatrix Medical and Paragonix Technologies.

When was BMI OrganBank founded?

BMI OrganBank was founded in 2005.

Where is BMI OrganBank's headquarters located?

BMI OrganBank's headquarters is located in Winston-Salem, NC, US.

How much has BMI OrganBank raised to-date?

As of Jan 12, 2026, BMI OrganBank has raised a total of $4.1M (USD).

BMI OrganBank - Classification

Industry: Biotechnology
Medical Devices
Ownership: Private
Geographic Exposure: Americas United States

Main Product: Medical Device

Tags: Healthcare